ATE99702T1 - Verfahren zur herstellung von reinem natuerlichen heparansulfat und dermatansulfat und ihre pharmazeutische verwendung. - Google Patents

Verfahren zur herstellung von reinem natuerlichen heparansulfat und dermatansulfat und ihre pharmazeutische verwendung.

Info

Publication number
ATE99702T1
ATE99702T1 AT86102963T AT86102963T ATE99702T1 AT E99702 T1 ATE99702 T1 AT E99702T1 AT 86102963 T AT86102963 T AT 86102963T AT 86102963 T AT86102963 T AT 86102963T AT E99702 T1 ATE99702 T1 AT E99702T1
Authority
AT
Austria
Prior art keywords
sulphate
sulfate
dermatan
processes
production
Prior art date
Application number
AT86102963T
Other languages
German (de)
English (en)
Inventor
Bono Rinaldo Del
Ambrosi Luigi De
Piergiuseppe Pagella
Gianni Ferrari
Original Assignee
Mediolanum Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Srl filed Critical Mediolanum Farmaceutici Srl
Application granted granted Critical
Publication of ATE99702T1 publication Critical patent/ATE99702T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0066Isolation or extraction of proteoglycans from organs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT86102963T 1985-03-13 1986-03-06 Verfahren zur herstellung von reinem natuerlichen heparansulfat und dermatansulfat und ihre pharmazeutische verwendung. ATE99702T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8519885A IT1208509B (it) 1985-03-13 1985-03-13 Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.

Publications (1)

Publication Number Publication Date
ATE99702T1 true ATE99702T1 (de) 1994-01-15

Family

ID=11162062

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86102963T ATE99702T1 (de) 1985-03-13 1986-03-06 Verfahren zur herstellung von reinem natuerlichen heparansulfat und dermatansulfat und ihre pharmazeutische verwendung.

Country Status (20)

Country Link
US (1) US4783447A (US06589383-20030708-C00041.png)
EP (1) EP0199033B1 (US06589383-20030708-C00041.png)
JP (1) JPS61218601A (US06589383-20030708-C00041.png)
KR (1) KR910006809B1 (US06589383-20030708-C00041.png)
AT (1) ATE99702T1 (US06589383-20030708-C00041.png)
AU (1) AU582221B2 (US06589383-20030708-C00041.png)
CA (1) CA1286286C (US06589383-20030708-C00041.png)
DE (1) DE3689493T2 (US06589383-20030708-C00041.png)
DK (1) DK113886A (US06589383-20030708-C00041.png)
ES (1) ES8705894A1 (US06589383-20030708-C00041.png)
FI (1) FI82700C (US06589383-20030708-C00041.png)
GR (1) GR860677B (US06589383-20030708-C00041.png)
IN (1) IN163616B (US06589383-20030708-C00041.png)
IT (1) IT1208509B (US06589383-20030708-C00041.png)
NO (1) NO166187C (US06589383-20030708-C00041.png)
NZ (1) NZ215435A (US06589383-20030708-C00041.png)
PH (2) PH22370A (US06589383-20030708-C00041.png)
PT (1) PT82198B (US06589383-20030708-C00041.png)
YU (1) YU46303B (US06589383-20030708-C00041.png)
ZA (1) ZA861855B (US06589383-20030708-C00041.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1189085B (it) * 1986-03-25 1988-01-28 Mediolanum Farmaceutici Srl Processo per la preparazione di dermatan solfato ad alta purezza e composizioni farmaceutiche che lo contengono
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
DE3639561A1 (de) * 1986-11-20 1988-06-01 Baumann Hanno Verfahren zur herstellung von nicht-thrombogenen substraten
IT1232939B (it) * 1987-11-06 1992-03-10 Opocrin Spa Eparan solfato caratterizzato da elevata attivita' antitrombotica, elevata biodisponibilita', assenza di attivita' anticoagulante; suo processo di estrazione da organi e da tessuti e relative composizioni farmaceutiche
MC2098A1 (fr) * 1988-06-03 1991-02-15 Italfarmaco Spa Sels de glycosaminoglycanes,procedes pour leur preparation et compositions pharmaceutiques les contenant
EP0421508B1 (en) * 1989-10-04 1993-12-15 Akzo Nobel N.V. Sulphated glycosaminoglycuronan with antithrombotic activity
AU6872691A (en) * 1989-10-27 1991-05-31 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
WO1991015217A1 (en) * 1990-04-06 1991-10-17 Washington University Anticoagulant oligosaccharides
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
FR2691066B1 (fr) * 1992-05-15 1995-06-09 Sanofi Elf Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.
IT1256236B (it) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
CN1115182A (zh) * 1993-09-30 1996-01-17 生化学工业株式会社 抗血栓剂
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
IT1296581B1 (it) * 1997-11-28 1999-07-14 Istituto Scient Di Chimica E B Materiali polimerici non trombogenici e ad esaltata compatibilita' con fluidi e tessuti organici
CN1371391A (zh) * 1999-06-30 2002-09-25 汉密尔顿市医院研究发展有限公司 抑制凝血相关凝血因子的肝素成分
CN1473061A (zh) * 2000-09-08 2004-02-04 ���ܶ�����ҽԺ�о���չ���޹�˾ 抗血栓形成的组合物
CN107098989A (zh) * 2017-04-27 2017-08-29 甘肃省金羚集团药业有限公司 一种肝素钠的制备方法
CN114478832B (zh) * 2022-02-14 2023-03-03 河北常山生化药业股份有限公司 从肝素钠副产物中提纯四种多糖类产品的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179566A (en) * 1963-05-16 1965-04-20 Canada Packers Ltd Purification of heparin
JPS5318520B2 (US06589383-20030708-C00041.png) * 1972-07-05 1978-06-15
AR207237A1 (es) * 1974-02-25 1976-09-22 Thomas A Procedimiento para obtener extractos biologicos estables liofilizados solubles constituidos por complejos proteicos termorresistentes
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
JPS58171403A (ja) * 1982-04-01 1983-10-08 Eisai Co Ltd ヘパラン硫酸の精製法
IT1189298B (it) * 1982-06-18 1988-02-04 Manetti & Roberts Italo Brit Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
FR2555993B1 (fr) * 1983-12-06 1986-11-07 Anic Spa Chitosanes 6-sulfates et procede pour leur preparation
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
IT1163772B (it) * 1983-07-13 1987-04-08 Baldacci Lab Spa Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
NZ215435A (en) 1989-01-06
ZA861855B (en) 1986-10-29
KR860007278A (ko) 1986-10-10
PT82198A (en) 1986-04-01
IT8519885A0 (it) 1985-03-13
EP0199033B1 (en) 1994-01-05
PH25136A (en) 1991-02-19
YU37586A (en) 1988-04-30
CA1286286C (en) 1991-07-16
FI861020A0 (fi) 1986-03-12
JPH0238601B2 (US06589383-20030708-C00041.png) 1990-08-31
ES8705894A1 (es) 1987-05-16
NO166187C (no) 1991-06-12
FI82700B (fi) 1990-12-31
DK113886D0 (da) 1986-03-12
AU5472786A (en) 1986-09-18
DK113886A (da) 1986-09-14
EP0199033A3 (en) 1988-03-30
YU46303B (sh) 1993-05-28
PT82198B (pt) 1988-02-17
IT1208509B (it) 1989-07-10
KR910006809B1 (ko) 1991-09-02
US4783447A (en) 1988-11-08
ES552898A0 (es) 1987-05-16
NO166187B (no) 1991-03-04
PH22370A (en) 1988-08-12
FI861020A (fi) 1986-09-14
EP0199033A2 (en) 1986-10-29
JPS61218601A (ja) 1986-09-29
FI82700C (fi) 1991-04-10
NO860940L (no) 1986-09-15
GR860677B (en) 1986-07-14
DE3689493T2 (de) 1994-04-28
IN163616B (US06589383-20030708-C00041.png) 1988-10-15
DE3689493D1 (de) 1994-02-17
AU582221B2 (en) 1989-03-16

Similar Documents

Publication Publication Date Title
ATE99702T1 (de) Verfahren zur herstellung von reinem natuerlichen heparansulfat und dermatansulfat und ihre pharmazeutische verwendung.
ATE81672T1 (de) Ein durch xanthomonas hergestelltes polysaccharidpolymer.
DE69830240D1 (de) Hyaluronsäure-gel, verfahren zur dessen herstellung und hyaluronsäure-gel enthaltendes medizinisches material
ATE66004T1 (de) Verfahren zur herstellung eines polyaethylens mit breiter und oder bimodaler molekulargewichtsverteilung.
NZ333925A (en) Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
DE69102101D1 (de) Verfahren zur Herstellung von hochreinen Kathoden auf Aluminiumbasis für Kathodenzerstäubung.
IT1290814B1 (it) Glicosaminoglicani aventi elevata attivita' antitrombotica
DE68915664D1 (de) Verfahren zur Herstellung von Rohreinheiten.
ATE84571T1 (de) Hirudin-varianten, deren verwendung und verfahren zu deren herstellung.
ES2048974T3 (es) Aparato para producir continuamente agua electrolizada.
DE68914236D1 (de) Verfahren zur Herstellung von Natriumhyaluronat durch Gärung.
IT1189298B (it) Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
DE69100943D1 (de) Mit metallischen schuppen oder metallisierten flocken versehene dekorfolie insbesondere zur herstellung von schichtstoffplatten.
ATE332706T1 (de) Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen
ATE261438T1 (de) Produkte für körperhygiene basierend auf lapacho extrakte enthaltend quercetin, deren herstellung und verwendung
DE413248T1 (de) Substanzen mit heparinaehnlicher struktur und verfahren zur herstellung.
ATE85893T1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
ITFI930160A1 (it) Processo ed apparecchiatura per la produzione di elettricita' con turbine a gas alimentate mediante derivati dal sorgo zuccherino o da culture analoghe
TAKEUCHI et al. Anticoagulant activities of acidic glycosaminoglycans cooperative action with AT III
IT8900650A0 (it) Processo industriale per la produzione di pannelli rivestiti in laminato plastico post-formabile con bordi smussati o bombati
DE69011683D1 (de) Verfahren zur Herstellung von Laminaten von ZnSe und ZnS.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties